Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Neoplasms 1Uterine Cervical Neoplasms 1Pelvic Neoplasms 1Pain, Postoperative 1Ovarian Cysts 1Neoplasm Metastasis 1Myofibroma 1Disease Progression 1Cholelithiasis 1Appendicitis 1

Interventions

Radiotherapy 4Surveys and Questionnaires 3Specimen Handling 2Iohexol 2Gemcitabine 2spartalizumab 1sodium thiosulfate 1serotonin adipinate 1liposomal doxorubicin 1X-Rays 1Watchful Waiting 1Vorinostat 1Surgical Procedures, Operative 1Sunitinib 1Solutions 1Serotonin 1Saline Solution 1Re-Irradiation 1Radiotherapy, Image-Guided 1Radiosurgery 1Probiotics 1Platinum 1Particle Accelerators 1Pafolacianine 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Lidocaine 1Ketamine 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pelvic Neoplasms × Lidocaine × Gynecologic × Clear all
NCT06631625 2024-10-08

Effect of Addition of Dexmedetomidine or Ketamine to Intravenous Infusion of Lidocaine on Proinflammatory Cytokines in Pelvi-abdominal Cancer Surgeries.

Alexandria University

Phase 1 Completed
45 enrolled
Gynecologic

Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡